Form 4: Scholar Rock Director Sells Shares to Cover Tax Obligations Under 10b5-1 Plan

Scholar Rock Holding Corp. Director Richard Brudnick sold a total of 6,075 shares of common stock on May 29, 2025, under a pre-arranged 10b5-1 plan to satisfy tax withholding obligations related to RSU vesting.

Summary

• Richard Brudnick, a Director of Scholar Rock Holding Corp. (SRRK), executed sales of common stock on May 29, 2025.
• A total of 6,075 shares were sold in two separate transactions.
• The sales were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on February 27, 2025.
• The primary purpose of these sales was to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• The first transaction involved the sale of 4,675 shares at a weighted average price of $29.6313, with individual prices ranging from $28.90 to $29.89.
• The second transaction involved the sale of 1,400 shares at a weighted average price of $30.0031, with individual prices ranging from $29.91 to $30.10.
• Following these transactions, Mr. Brudnick beneficially owns 15,057 securities, consisting of 7,425 shares of common stock and 7,632 Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: The sale of shares by a director was conducted under a pre-arranged 10b5-1 plan specifically to cover tax withholding obligations upon RSU vesting, which is a routine and often non-discretionary event for insiders and does not typically indicate a negative outlook on the company's prospects.

Positives

• The sale was pre-planned under a Rule 10b5-1 trading plan, indicating a structured and pre-determined transaction rather than a discretionary sale based on immediate market views.
• The stated reason for the sale is to cover tax withholding obligations, which is a common and often non-discretionary reason for insider sales, rather than a reflection of a negative outlook on the company.

Negatives

• A reduction in direct insider ownership, even if for tax purposes, slightly decreases the alignment of the director's personal financial interest with that of common shareholders.

Risks

• No specific risks related to the company's operations or financial health are mentioned in this Form 4 filing. The only 'risk' is the general perception of insider selling, which is mitigated by the stated reason (tax withholding) and 10b5-1 plan.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The document does not contain direct quotes or paraphrased statements from company management, beyond the factual reporting of the transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis within the biotechnology or pharmaceutical sectors.

Comparison to Industry Standards

• This document, being an insider transaction report, does not contain information that allows for a direct comparison to global benchmarks, comparable companies, projects, or results in terms of financial performance or operational metrics.

Related Party Transactions

• The reported sale of common stock by Director Richard Brudnick to cover tax obligations related to RSU vesting constitutes a related party transaction, as it involves an insider of the company.

Stakeholder Impact

• Shareholders: The sale slightly reduces the direct ownership stake of a director, which could be perceived neutrally given the tax-related reason and 10b5-1 plan, or slightly negatively by those who prefer increasing insider ownership.
• Employees: The transaction relates to the vesting of Restricted Stock Units (RSUs), which are a form of employee compensation, indicating the ongoing operation of the company's equity incentive plans.

Next Steps

• The document does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the completion of the reported transaction.

Key Dates

Keywords

Scholar Rock Holding Corp, SRRK, Richard Brudnick, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Restricted Stock Units, RSU, Tax Withholding, Biotechnology, Pharmaceuticals, Director